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Hepatitis C virus (HCV) RNA binds to several cellular proteins, which may regulate translation or replication of viral RNA.
One of these is polypyrimidine tract-binding protein (PTB), which binds to the 59-untranslated region (UTR) and the 39-end 98
nucleotides (nt) (X region) of HCV RNA. Both of these PTB-binding sites regulate HCV translation. In this study, we further
investigated the nature of PTB binding on HCV RNA. UV cross-linking studies using HeLa cell extracts and a recombinant PTB
showed that the PTB–59-UTR binding was much weaker than the PTB–39-UTR binding. Unexpectedly, we found an even
stronger PTB-binding site in the core-protein-coding region of HCV RNA. The binding domain was mapped to the 39-end of
this region, which contains a pyrimidine-rich sequence highly conserved among HCV isolates. Using a set of synthetic HCV
RNAs with or without this sequence in in vitro translation studies, we showed that the PTB-binding sequence in the
core-coding region strongly inhibited translation of HCV RNA. This inhibition was relieved by the presence of the X region
at the 39-end. Furthermore, the previously reported translational enhancement by the HCV 39-UTR was more pronounced
when this PTB-binding site was present in the RNA. These results suggest that PTB binding to an internal site of HCV RNA
provides another mechanism for regulation of HCV translation. © 1999 Academic PressINTRODUCTION some entry site (IRES), and the sequence and structure
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HMany RNA viruses utilize host cellular factors to reg-
late their translation, replication, and/or transcription
see Lai (1998) for a review]. Hepatitis C virus (HCV)
rovides such an example. It contains a 9.6-kb single-
tranded, positive-sense RNA genome, which encodes a
arge polyprotein of about 3010–3033 amino acids (Choo
t al., 1989; Kato et al., 1990). While the overall sequence
f HCV RNA shows considerable diversity among vari-
us isolates (Bukh et al., 1995), the 59-untranslated re-
ion (UTR) and the 39-end 98 nucleotides (nt) (X region) of
he HCV RNA are highly conserved (Bukh et al., 1992;
olykhalov et al., 1996; Tanaka et al., 1996), suggesting
heir functional importance, probably in viral replication
nd/or translation.
The 39-end X region has been reported to bind a
ellular protein polypyrimidine-tract-binding protein
PTB) (Ito and Lai, 1997; Tsuchihara et al., 1997), which is
pre-mRNA splicing factor (Patton et al., 1991) and binds
o several other viral RNAs as well (Lai, 1998). The X
egion enhances HCV translation from an internal ribo-
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288f the PTB-binding site are important for this enhance-
ent effect (Ito et al., 1998). PTB has also been reported
o bind to the IRES in the 59-UTR of HCV RNA and
egulate HCV translation (Ali and Siddiqui, 1995), al-
hough this finding has been disputed (Kaminski et al.,
995; Reynolds et al., 1995). In the 59-UTR of HCV RNA,
everal other cellular factors, including La antigen and
nRNP L, have been identified to bind and regulate its
ranslation (Ali and Siddiqui, 1997; Fukushi et al., 1997;
ahm et al., 1998). These observations strongly suggest
hat host cellular factors binding to both ends of the HCV
NA are involved in the regulation of translation.
In this study, we further investigated the nature of PTB
inding to both the HCV 59-UTR and the 39-UTR. We
ound that PTB binding to the 59-UTR is significantly
eaker than that to the X region. Unexpectedly, another
TB-binding site was discovered in the core-protein-
oding region of HCV RNA. The binding domain was
apped to the 39-end of this region, which contains a
ighly conserved pyrimidine-rich sequence. Further-
ore, the PTB-binding sequence at the core-protein-
oding region strongly attenuated HCV translation, which
ould be relieved by the X region at the 39-end of the
NA. The presence of this sequence accounted for a
ignificant part of the translational enhancement effects
aused by the 39-UTR of HCV. This property provides an
dditional mechanism for regulation of translation of
CV RNA.
RESULTS
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289TRANSLATIONAL REGULATION OF HCVTB binding at the 59-end of HCV RNA requires the
ore-protein-coding sequence
Previously it has been shown that PTB binds to both
he 59- and the 39-UTRs of HCV RNA (Ali and Siddiqui,
995; Ito and Lai, 1997; Tsuchihara et al., 1997). To com-
are its relative binding strength to either end of the
NA, we carried out a UV cross-linking experiment using
2P-labeled RNAs of HCV 39-X, the 59-UTR alone, the
9-UTR plus the 59-end of the core-coding sequence (nt
42–512 from the 59-end), and the 59-UTR plus the entire
ore-coding sequence (nt 342–914). When HeLa cell ex-
racts were used, a 58-kDa protein, which was previously
dentified as PTB (Ito and Lai, 1997), was found to cross-
ink to the 39-UTR (Fig. 1A, lane 1). However, PTB was not
ross-linked to the 59-UTR (lane 2), in contrast to the
revious report (Ali and Siddiqui, 1995). Instead, several
maller proteins were detected to bind to the 59-UTR; the
ature of these proteins has not been identified. The lack
f PTB binding to the 59-UTR of HCV RNA was confirmed
y the competition assay, in which a 500 times molar
xcess of the unlabeled 59-UTR RNA could not abolish
he PTB–39-X binding (Fig. 1B), whereas only a 5-fold
olar excess of the 39-X region RNA almost completely
bolished the PTB–39-X binding (Ito and Lai, 1997) (data
ot shown). Unexpectedly, when the 59-UTR RNA plus the
ntire core-coding sequence [59-UTR1core(342-914)]
as used, a very strong PTB binding was observed (Fig.
A, lane 4). A smaller RNA containing the 59-UTR plus the
9-end of the core-protein-coding sequence did not bind
his protein (Fig. 1A, lane 3). These results suggest that
he 39-half of the core-protein-coding sequence contains
previously undetected PTB-binding site. The binding
ffinity of PTB to this region was at least as strong as that
o the 39-UTR. Immunoprecipitation of this UV cross-
inked protein by a PTB-specific antibody, but not by the
ntibody against an unrelated protein (TATA-binding pro-
ein), confirmed that the 59-UTR plus the entire core-
oding RNA bound PTB (Fig. 1C).
When a recombinant glutathione S-transferase (GST)–
TB was used for UV cross-linking, a weak binding
etween PTB and the 59-UTR RNA was observed (Fig.
A, lane 6), but it was considerably weaker than its
inding to the 39-UTR (lane 5). When the 59-end of the
ore-coding sequence [59-UTR1core(342-512)] was
oined to the 59-UTR, the amount of PTB binding was
nhanced (lane 7). Significantly, when the entire core-
rotein-coding region was included, the PTB binding
as even stronger than that to the 39-UTR (lane 8). These
esults combined indicate that the core-protein-coding
egion contains a strong PTB-binding site and that the
reviously reported PTB binding to the 59-UTR region (Ali
nd Siddiqui, 1995) is very weak at best.apping of the PTB-binding site in the core-coding
egion of HCV RNA
To map the PTB-binding site in the core-coding region,
e performed the UV cross-linking experiment using the
FIG. 1. UV cross-linking analysis of HCV RNA with HeLa cell extracts
nd a recombinant GST–PTB. (A) UV cross-linking of proteins from cyto-
lasmic extracts of HeLa cells (lanes 1–4) and GST–PTB (lanes 5–8) to the
arious RNAs. 20 mg of HeLa extracts or 50 ng of GST–PTB was mixed
ith 32P-labeled RNA, UV-irradiated, digested with RNase A, and sepa-
ated by SDS–PAGE on 10% polyacrylamide gels. Arrows indicate the
ST–PTB (86 kDa) and the endogenous PTB (58 kDa) in HeLa cells.
olecular mass markers are indicated on the left. (B) Competition analysis
f UV cross-linked PTB. A fixed amount of the 32P-labeled 39-UTR-X RNA (2
mol of RNA) was UV cross-linked with a fixed amount of HeLa cytoplas-
ic extracts (20 mg). Increasing amounts of the unlabeled HCV 59-UTR
NAs were used as a competitor. (2) Lane, no competitor. Lanes 2 to 5,
-, 5-, 50-, and 500-fold molar excesses of unlabeled HCV-59-UTR over the
2P-labeled 39-UTR–X, respectively. (C) Immunoprecipitation of the UV
ross-linked proteins. A monoclonal anti-PTB antibody (lanes 2 and 4) and
monoclonal anti-TBP antibody (lanes 3 and 6) were used to immuno-
recipitate the proteins cross-linked to HCV-X(1) RNA (lanes 1–3) or
9-UTR1core(342-914) RNA (lanes 4–6). Lanes 1 and 4, UV cross-linked
roteins without immunoprecipitation.
entire core-coding RNA [core(342-914)] and its 39-end
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290 ITO AND LAIruncation mutants [core(342-854), core(342-800), and
ore(342-686)]. Figure 2A shows that only the core(342-
14) RNA bound PTB from the HeLa cell lysates, sug-
esting that the PTB-binding site is located at the 39-end
f the core-coding region (nt 854–914). The competition
ssay using the recombinant GST–PTB binding to the
2P-labeled core(342-914) RNA showed that only the
ore(342-914) RNA, which contains the entire core-cod-
ng region, but not core(342-800) RNA, inhibited the PTB
inding (Fig. 2B), confirming that the PTB-binding site is
t the 39-end of the core-coding region. As expected, the
2P-labeled core(342-800) RNA did not bind GST–PTB
lanes 1–4).
We also performed a gel-mobility shift assay using
2P-labeled core(342-914) RNA to further assess the
pecificity of the PTB–RNA binding. Figure 2C shows that
n RNA–protein complex of slower electrophoretic mo-
ility was formed between the recombinant PTB and the
ntire core-coding RNA (lane 3). The formation of this
NA–protein complex was inhibited by an excess of
ore(342-914) RNA but not core(342-800) RNA (lanes 4
nd 5). Interestingly, HCV core protein, which has been
hown to have general RNA-binding activities (Hwang et
l., 1995; Santolini et al., 1994), did not form an RNA–
rotein complex with the core-coding RNA under these
onditions (lane 2). These results further confirm that the
9-end of the core-coding region of HCV RNA has a
trong and specific PTB-binding site (Fig. 3A). This re-
ion contains a stretch of pyrimidine-rich sequence,
hich is highly conserved among various HCV isolates
Fig. 3B). This sequence conservation suggests that PTB
an bind to this region in almost all HCV isolates. GST–
TB also appeared to bind to other regions of the core-
oding sequence weakly; the specificity of these bind-
ngs was not further evaluated.
he PTB-binding sequence in the core-coding region
nhibits the translation of HCV RNA
To investigate the biological significance of PTB bind-
ng at the core-coding region, we studied whether this
egion affected the translation of HCV RNA, since the
inding of PTB to both ends of HCV RNA (Ali and Sid-
iqui, 1995; Ito and Lai, 1997; Tsuchihara et al., 1997) has
een shown to enhance IRES-dependent translation (Ito
t al., 1998). We used a reporter RNA (HCV-5CL), which
ontains the 59-UTR and the entire core-coding region of
CV preceding the luciferase (LUC) gene, and a corre-
ponding RNA, HCV-5CLD752-914, which has the PTB-
inding site deleted, for in vitro translation in rabbit
eticulocyte lysates (Fig. 4A). Figures 4B and 4C show
hat HCV-5CL RNA was translated very poorly (lane 1),
hereas the corresponding deletion mutant RNA was
ranslated three- to fourfold more efficiently (lane 2),
ndicating that the PTB-binding sequence at the 39-end of
he core-coding region strongly inhibited its translation.he addition of the X sequence to the 39-end of 5CL RNA
HCV-5CL-X) enhanced the translation to almost the
ame level as the HCV-5CLD752-914 (lane 3), indicating
FIG. 2. Mapping of the PTB-binding sites in the core-coding region of
CV RNA. (A) UV cross-linking using cytoplasmic extracts of HeLa cells
nd various 32P-labeled RNAs. (B) Competition analysis of UV cross-
inked GST–PTB. A fixed amount of the 32P-labeled HCV core(342-800)
lanes 1–4) or core(342-914) (lanes 5–11) RNA (2 pmol of RNA) was UV
ross-linked with a fixed amount of GST–PTB (50 ng). Increasing
mounts of the unlabeled HCV core(342-800) (lanes 2–4 and 6–8) and
ore(342-914) (lanes 9–11) RNAs were used as a competitor. (2) Lane,
o competitor. Lanes 2–4, 6–8, and 9–11, 1-, 10-, and 50-fold molar
xcesses over the radiolabeled probe, respectively. (C) Gel-mobility
hift assay of RNA–protein complexes. 32P-labeled core(342-914) RNA
as mixed with GST–core protein (lane 2) or GST–PTB that had been
redigested with thrombin (lanes 3–5) and various unlabeled compet-
tor RNAs. The RNA–protein complexes were separated in 3% poly-
crylamide gels under nondenaturing conditions.
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291TRANSLATIONAL REGULATION OF HCVhat the X region, which binds PTB, can relieve the
nhibitory effects of the PTB-binding sequence in the
ore-protein-coding region of HCV RNA. The effects of
he 39-end X region on both RNAs with or without the
TB-binding site in the core-protein-coding region were
urther assessed. Comparison of lanes 1 and 3 indicated
hat the X region enhanced the translation on the RNA
hat contains this internal PTB-binding site by three- to
ivefold (Fig. 4B and 4C), consistent with the previous
bservation (Ito et al., 1998). However, on the RNAs that
o not have this internal PTB-binding site, the translation
nhancement by the X sequence was less than twofold.
imilar results were obtained when the LUC activities of
he various translation products were measured (Fig.
C). These results combined suggest that the PTB-bind-
ng sequence in the core-coding region serves as a
ranslational repressor and that the 39-end X sequence,
hich also binds PTB, relieves this translational inhibi-
ion.
To investigate whether the translational inhibition by
he PTB-binding site was due to destabilization of mRNAs,
e monitored the stability of these RNAs in reticulocyte
ysates during in vitro translation, by a primer extension
tudy using a primer complementary to the 59-UTR se-
uence. Figure 4D shows that the kinetics of mRNA
FIG. 3. (A) Diagram of the structure of HCV RNA constructs and the
xpressed in semiquantitative terms. (B) Nucleotide sequences of the po
solates (Bukh et al., 1992). Numbers on the top represent the nucleoti
n the left.egradation were similar for HCV-5CL and HCV-
CLD752-914, indicating that these RNAs had compara-
le stability and that the translation-inhibition effect of
he PTB-binding site in the core-coding region was not
ue to RNA destabilization by this site.
DISCUSSION
Our previous works have shown that stem loops 2 and
of the X region of the 39-UTR of HCV RNA bind PTB (Ito
nd Lai, 1997) and that this X region enhanced HCV
ranslation from an IRES; mutations at the PTB-binding
equence reduced the level of the translational enhance-
ent (Ito et al., 1998). From these results, we speculated
hat the binding of PTB to the X region enhanced the
ranslation of HCV RNA by a mechanism similar to that of
he poly(A) tail in eukaryotic mRNAs. The poly(A) tail
inds a poly(A)-binding protein (Pab1p), which has been
hown to interact with the 59-end of mRNAs through
dditional cellular factors (Craig et al., 1998; Tarun and
achs, 1996), resulting in the circularization of mRNA
Wells et al., 1998). The communication between the
9-end and the 39-poly(A) tail of eukaryotic mRNA en-
anced translation efficiency (Craig et al., 1998; Munroe
nd Jacobson, 1990; Tarun et al., 1997). PTB has also
binding. The relative extents of PTB binding to the various RNAs are
PTB-binding site in the HCV core-coding region among individual HCV
bers from the 59-end of the HCV RNA. HCV genotypes are describedir PTB
tential
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292 ITO AND LAIeen reported to interact with the IRES of HCV, raising
he possibility that PTB has a bridging role for both ends
f the HCV RNA (Ali and Siddiqui, 1995), similar to that of
ab1p for eukaryotic mRNAs.
Our studies presented here showed that PTB–59-UTR
inding was much weaker than PTB–39-X binding. Using
eLa cell extracts, the PTB–59-UTR binding could not be
emonstrated (Fig. 1A); only when a purified recombi-
ant GST–PTB was used did a weak binding become
etectable. Furthermore, unlabeled 59-UTR RNA could
ot inhibit the binding between the 39-X and PTB even at
500-fold molar excess (Fig. 1C), whereas the homolo-
ous RNA could abolish this binding at a 5-fold molar
xcess (Ito and Lai, 1997), suggesting that PTB–59-UTR
inding is at least 100-fold weaker than the correspond-
ng PTB–39-UTR binding. This finding is consistent with
n earlier report that PTB failed to bind to an RNA
onsisting of the 59-UTR plus 11 nt of the core-coding
egion (Kaminski et al., 1995). Kaminski et al. also con-
luded that PTB itself did not affect HCV translation,
lthough the RNA used in that study did not contain the
FIG. 4. Functional analysis of the PTB-binding site in the core-codin
his study. pHCV-5CL-X contains T7 promoter (large open arrow), 59-UT
o LUC genes (open box), and the HCV 39-X region in the pGL vector
HCV-5CL-X. (B) In vitro translation products of various RNAs. In vitro
he translation products were separated by SDS–PAGE on 10–20% polya
nd relative amounts of the core–LUC fusion protein were determined.
UC activity of the in vitro translation products of various RNAs. The L
epresent the means and standard deviations of two sets of triplicate s
f each RNA was mixed with rabbit reticulocyte lysates. At 0, 30, 60, and
or primer extension experiments using a 59-UTR primer. Arrow indicat
ntact 59-end of HCV RNA.region at the 39-end (Kaminski et al., 1995). These
esults suggest that the HCV 39-end is unlikely to interact
ith the 59-end through PTB alone. Blight and Rice (1997)
lso showed that the 39-X sequence could not interact
ith the 59-UTR directly. All of these findings suggest that
ther cellular factors, in addition to PTB, are required for
he interaction between the 59- and the 39-ends of HCV
NA to account for the 39-UTR-mediated enhancement of
CV translation (Ito et al., 1998).
Unexpectedly we found that PTB bound to the 39-end
f the core-coding region, instead of the 59-UTR, in HCV
NA (Fig. 2). This binding was at least as strong as its
inding to the 39-X region. This PTB-binding site contains
pyrimidine-rich sequence, which is conserved among
ll HCV isolates (Bukh et al., 1995), suggesting the func-
ional importance of this region (Fig. 3B). Interestingly,
eletion of this PTB-binding site increased the level of
ranslation of the HCV RNA, which does not have the X
egion at the 39-end, suggesting that this internal PTB-
inding site serves as a translational attenuator. This
ranslational inhibition was not due to RNA destabiliza-
n by in vitro translation. (A) Schematic diagrams of the RNAs used in
e line), core-encoding region (hatched box) of the HCV 1b strain fused
ga). pHCV-5CL-XD752-914 has a deletion of the nt 752–914 region in
tion was carried out in rabbit reticulocyte lysates at 120 mM KCl, and
ide gradient gels. The autoradiogram was scanned by NIH image 1.62,
nslation product of HCV-5CL RNA is artificially set at 100%. (C) Relative
vity of HCV-5CL RNA is artificially set at 100%. The columns and bars
(D) RNA stability of HCV-5CL (left) and -5CLD752-914 (right) RNA. 2 mg
after in vitro translation, RNAs were harvested and used as a template
primer-extended products (265 nt in length), which correspond to theg regio
R (singl
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293TRANSLATIONAL REGULATION OF HCVion by this PTB-binding site, since the kinetics of RNA
egradation was similar between HCV-5CL and -5CL-
D752-914 RNAs (Fig. 4C). Surprisingly, most of the trans-
ational attenuation caused by this internal PTB-binding
ite was relieved by the presence of the X region at the
9-end, again suggesting a long-distance interaction be-
ween the 39- and the 59-ends or between the 39-end and
he internal PTB-binding site. Previously we reported that
he 39-end X region enhanced translation of HCV-5CL
NA by three- to fivefold (Ito et al., 1998); this finding was
onfirmed in this study (Fig. 4B). However, when the
nternal PTB-binding sequence was deleted, the 39-X-
ediated translation enhancement was not more than
wofold (Figs. 4B and 4C, compare HCV-5CLD752-914
nd HCV-5CL-XD752-914). Thus, the 39-X-mediated trans-
ation enhancement of HCV RNA (Ito et al., 1998) is partly
ue to the relief of the translational suppression by the
nternal PTB-binding site in the core-protein-coding re-
ion. Since this sequence is present in the full-length
CV RNA, both the positive regulation and the negative
FIG. 4egulation of translation by the PTB-binding sequences
re likely to be biologically relevant in HCV infection.
his finding also shows that the effects of translational
nhancement by the 39-UTR of HCV were best demon-
trated using RNAs that contain the complete core-pro-
ein-coding region following the 59-UTR of HCV RNA (Ito
t al., 1998). In any case, the inclusion of more HCV
equences would more likely reflect the mechanism of
he translational regulation in the natural HCV life cycle.
Pestova et al. (1998) reported that the constitution of the
ukaryotic initiation factors at the IRES of HCV RNA was
ifferent from that of other IRES-containing viral RNAs. They
howed that only eIF3 bound to HCV IRES, similar to pro-
aryotic mRNAs (Pestova et al., 1998; Sizova et al., 1998).
hus, it is unlikely that the HCV 39-UTR interacts with the
9-end through the same set of translation initiation factors
s eukaryotic mRNA does. Although the role of PTB in the
ranslation of HCV RNA has not been directly demon-
trated, the fact that all of the PTB-binding sites on the HCV
NA can regulate HCV translation suggests that PTB likely
inued—Cont
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294 ITO AND LAIlays an important role in translation. It is possible that PTB
ay bind to eIF-3 to effect 59- and 39-end interactions.
urthermore, other cellular and/or viral factors may bind to
CV RNA to play a bridging role between the 59- and the
9-ends. Several such factors have been reported to bind
he 59-UTR of HCV RNA (Ali and Siddiqui, 1997; Fukushi et
l., 1997; Hahm et al., 1998); some of these may interact with
TB.
Based on these findings, we propose a working model
or the translational regulation of HCV RNA (Fig. 5). At the
RES of HCV RNA, an unknown factor (Y) interacts with
oth viral RNA and PTB. When the factor Y interacts with
he PTB at the core-coding region, HCV translation is
nhibited because of the steric hindrance of RNA struc-
ure (Fig. 5A). When the 39-end X region is present, the
actor Y will interact with the PTB at the 39-X region
nstead, preventing its binding with the PTB at the core-
oding region and thus allowing elongation of transla-
ion. At the same time, the circularization of RNA medi-
FIG. 5. A proposed model for translational regulation of HCV RNA. (A)
n the absence of the X region at the 39-end, an unknown factor (Y)
inds to the IRES in the 59-UTR and interacts with PTB at the 39-end of
he core-coding region. These interactions inhibit ribosome scanning
n HCV RNA because of the steric hindrance of RNA structure. (B) In
he presence of the X region at the 39-end, the Y factor binds to the
9-end of the HCV RNA through PTB, preventing the binding of the Y
actor with the PTB at the core-coding region and thus allowing trans-
ational elongation. The interaction between the 59- and the 39-ends
lso enables HCV RNA to be circularized to enhance translational
nitiation.ranslational initiation of viral RNA (Fig. 5B).
Finally, what is the biological significance of transla-
ional suppression exerted by an internal PTB-binding
NA sequence? One possibility is that this regulatory
echanism ensures that only the full-length HCV RNA
an be efficiently translated. When HCV RNA is de-
raded from the 39-end and loses the X region, transla-
ion of the degraded RNA will be strongly inhibited be-
ause of the internal PTB-binding sequence. Another
ossibility is that PTB binding to an internal site of viral
NA may be fortuitous, due to the random occurrence of
he pyrimidine-rich sequence. This binding will inhibit
ranslation, which must be relieved by some mechanism,
uch as PTB binding at the 39-UTR (Fig. 5A). Thus, the
nteraction between PTB and the HCV RNA genome at
he 39-UTR and an internal region may provide both
ositive and negative regulation of translation.
MATERIALS AND METHODS
onstruction of cDNA clones
To generate in vitro transcripts of the various regions
f HCV RNA, plasmid HCV-X(1) (Ito and Lai, 1997), which
ontains the core-coding region of HCV-T cDNA
core(342-914)] (Chen et al., 1992) and its deletion mu-
ants [core(342-854), core(342-800) and core(342-686)],
nd the plasmid containing the entire HCV cDNA of
CV-1 isolate (Choo et al., 1989) were used as templates.
hese plasmids contain the T7 promoter upstream of the
CV sequence.
The construction of the plasmid pGEX-PTB has been
escribed previously (Ito and Lai, 1997). The pGEX-HCV
ore, which encodes the GST-HCV core fusion protein,
as constructed from the HCV cDNA of HCV RH isolate
Lo et al., 1995).
Plasmid pHCV-5CL-X was constructed as described pre-
iously (Ito et al., 1998). To construct pHCV-5CL-XD752-914,
hich is a deletion mutant of pHCV-5CL-X, the cDNA frag-
ent containing the T7 promoter, the 59-UTR, and a trun-
ated core-coding region (752–914 nt) of HCV RNA was
ubcloned to pGL-basic vector (Promega), and the HCV-X
equence was inserted following the LUC gene.
n vitro RNA transcription
To synthesize RNA in vitro, various DNAs were linear-
zed with the appropriate restriction enzymes and sub-
ected to in vitro transcription using T7 RNA polymerase
Promega). In vitro transcription was carried out accord-
ng to the manufacturer’s recommended procedure (Pro-
ega). 32P-labeled RNAs were obtained by transcription
n the presence of 50 mCi of [a-32P]UTP [3000 Ci/mmol
ICN Biomedicals)], 12.5 mM UTP, and 500 mM each of
TP, GTP, and CTP. Unlabeled RNAs were transcribed in
he presence of 500 mM each of ATP, GTP, CTP, and UTP.
fter incubation at 37°C for 2 h, 1 U of RQ DNase I
(Promega) was added to the reaction mixture to digest
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295TRANSLATIONAL REGULATION OF HCVNA templates, and the transcribed RNAs were purified
ith a Sephadex G-25 column equilibrated in STE buffer
10 mM Tris–HCl, 1 mM EDTA, 0.1 mM NaCl (pH 7.5)] to
emove unincorporated ribonucleotides and deoxyribo-
ucleotides from DNA digestion. The radioactivity of the
ranscription product was determined with a liquid scin-
illation counter (LC6000 IC; Beckman).
reparation of recombinant proteins
GST-PTB and GST-core fusion proteins were induced
y isopropyl-thiogaractopyranocyde in Escherichia coli
ccording to the published method (Frangioni and Neel,
993), purified by binding to glutathione–Sepharose 4B
eads (Pharmacia), and recovered by elution with 10 mM
educed glutathione. For gel-mobility shift assay, GST-
TB was treated with thrombin to remove the GST part of
he fusion protein before use.
V cross-linking of RNA–protein complexes
Cytoplasmic extracts of HeLa cells and GST-PTB fu-
ion protein were prepared as previously described (Ito
nd Lai, 1997). For UV cross-linking of RNA to proteins,
0 mg of HeLa cytoplasmic extracts or 50 ng of GST-PTB
as first mixed with 20 mg of yeast tRNA in a final volume
f 20 ml of binding buffer [5 mM HEPES (pH 7.8), 25 mM
Cl, 2 mM MgCl2, 3.8% glycerol, 0.1 mM EDTA, 2 mM
TT]. In competition assays, different amounts of unla-
eled RNA were mixed with a fixed amount of protein in
he binding buffer. The amounts of the unlabeled com-
etitor RNAs were predetermined with a spectrophotom-
ter. Following incubation at 30°C for 10 min, 32P-labeled
NA (2 pmol of RNA) was added, and the reaction mix-
ure was incubated for an additional 10 min. Subse-
uently, the reaction mixture was irradiated with UV light
254 nm) (UV Stratalation 2400; Stratagene) on ice at a
istance of 13 cm for 10 min. After irradiation, RNase A
as added to a final concentration of 2 mg/ml, and the
ixture was incubated for 30 min at 37°C, boiled for 3
in in the sample buffer [10% glycerol, 200 mM DTT, 3%
odium dodecyl sulfate (SDS), 62.5 mM Tris–HCl (pH
.8)], and electrophoresed on a 10% polyacrylamide gel
ontaining 0.1% SDS. After being dried, the gel was
xposed to X-ray film.
mmunoprecipitation of UV cross-linked protein
After UV cross-linking of HeLa cytoplasmic extracts to
2P-labeled HCV RNA and RNase treatment as described
bove, the sample was diluted to 500 ml with NETS buffer
50 mM Tris–HCl (pH 7.4), 5 mM EDTA, 1 mM DTT, 100
M NaCl, and 0.05% NP-40] and mixed with monoclonal
ntibodies against either PTB (Ito and Lai, 1997) or TATA-
inding protein (TBP) (TFIID, Calbiochem). The immuno-
omplexes were immobilized on protein A–Sepharose
B beads saturated with anti-mouse IgG antibodies (Sig-
a). The unbound materials were washed five times withDS–PAGE and identified by autoradiography.
el-mobility shift assay
The gel-mobility shift assay was carried out essentially
s described previously (Furuya and Lai, 1993) with slight
odification. Briefly, 500 ng of recombinant proteins was
irst mixed with 20 mg of yeast tRNA in a final volume of
0 ml of binding buffer [5 mM HEPES (pH 7.8), 25 mM KCl,
mM MgCl2, 3.8% glycerol, 0.1 mM EDTA, 2 mM DTT].
ollowing incubation at 30°C for 10 min, 32P-labeled RNA
2 pmol of RNA) was added, and the reaction mixture
as incubated for an additional 10 min. The reaction
ixture was then mixed with 1⁄5 vol of 53 loading buffer
50% glycerol, 0.05% bromophenol blue, 0.05% xylen cya-
ol] and separated by electrophoresis on a 3% polyacryl-
mide gel made in 0.53 TBE [45 mM Tris–borate, 1 mM
DTA]–5% glycerol. The polyacrylamide gels had been
reelectrophoresed at 200 V for 30 min prior to loading of
he samples, and electrophoresis was performed at 200
at room temperature for 2 h. After being dried, the gel
as exposed to X-ray film.
n vitro translation
In vitro translation was carried out in micrococcal
uclease-treated rabbit reticulocyte lysates (Flexi; Pro-
ega). Translation reactions (25 ml) were programmed
ith 2 mg of RNA, 10 ml of lysates, 0.5 U of RNase
nhibitor (RNasin; Promega), 2 mM dithiothreitol, 20 mM
mino acid mixture minus methionine, and 120 mM KCl
n the presence of 1 ml of [35S]methionine (10 mCi/ml;
EN) and carried out at 30°C for 90 min. At the end of the
eactions, stop buffer [50 mg/ml RNase A, 10 mM EDTA
pH 7.5)] was added to the reaction mixture. Aliquots of
he translation products were separated by SDS–PAGE.
he dried gel was autoradiographed and the radioactiv-
ties of the specific bands were quantitated by National
nstitutes of Health image 1.62 (Brown et al., 1998).
rimer extension
Two-microgram quantities of various RNAs were incu-
ated with rabbit reticulocyte lysates in the presence of
20 mM KCl under the conditions for in vitro translation.
otal RNA was extracted from the lysates at 0, 30, 60, and
0 min after the reaction using Trizol reagent (Gibco BRL)
nd analyzed by primer extension using a 32P-end-la-
eled primer (59-AACACTACTCGGCTAGCAGT-39) com-
lementary to the 59-UTR of HCV RNA as previously
escribed (Ito et al., 1998).
UC assays
For LUC assay of the in vitro translation product, 5 ml
f reaction mixture was mixed with 100 ml of Luciferase
ssay reagent (Promega), and the LUC activity was mea-
ured after 20 s by Luminometer (Berthold).
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